The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 344:457-458 February 8, 2001 Number 6
NextNext

Ibuprofen versus Indomethacin for Closure of Patent Ductus Arteriosus

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Van Overmeire et al. compared ibuprofen with indomethacin for closure of patent ductus arteriosus in premature neonates (Sept. 7 issue).1 They found that the rates of ductal closure were similar in the two treatment groups but that indomethacin was more likely to be associated with oliguria. However, the dosage of indomethacin in this study was 0.2 mg per kilogram of body weight given intravenously at 12-hour intervals for a total of three doses.

Rennie and Cooke2 compared a regimen of 0.2 mg per kilogram given at 12-hour intervals for a total of three doses with a regimen . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.